Cleveland Clinic European Society of Cardiology 2016 Symposium

Management of Statin Intolerant High Risk Patients: What Are The Current Options

By Cleveland Clinic European Society of Cardiology 2016 Symposium
By Cleveland Clinic European Society of Cardiology 2016 Symposium
1,018 views
September 16, 2016
1 Comment
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
19:09
ACC 2023 Conference Coverage

ACC 2023: Management of Statin Side Effects and How to Keep Them on …

Feat. J. Saseen
24:02
Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus
24:10
ACC 2022 Conference Coverage

ACC 2022: How I Manage Statin-associated Muscle Symptoms and Other B…

Feat. P. Toth
18:44
National Lipid Association

NLA Scientific Statement on Statin Intolerance: A New Definition and…

Feat. M. Cheeley
42:28
Houston Methodist DeBakey Heart and Vascular Center

Treatment of Lipids in 2023: Where Are We Now and Where Are We Going?

Feat. C. Ballantyne
28:09
ASPC 2019 Congress on CVD Prevention

LDL-C lowering and the Brain: Differentiating Fact from Fiction

Feat. P. Toth
13:16
Rhonda Cooper-DeHoff

Diagnosing Statin Intolerance

15:26
Mike Kelly

Diagnosis and Definition of Statin Intolerance

10:50
MUSC Cardiology

Clear Outcomes - The First (and Only) Trial in Statin Intolerant Pat…

Feat. M. Budoff
10:14
The Texas Heart Institute

Non-Statin Therapies, Expert ACC Consensus

Feat. C. Ballantyne
49:00
Penn Medicine Heart and Vascular Center

Anti-Inflammatory Therapies in Cardiovascular Diseases

Feat. A. Abbate
25:22
Cardiometabolic Health Congress (CMHC)

Non-Statin Drugs and New Approaches

Feat. M. Sabatine, C. Ballantyne
12:11
AHA 2023 Insights

AHA 2023 Insights: Inflammation and Cholesterol as Predictors of Car…

Feat. P. Ridker
17:23
National Lipid Association

ACC/AHA Cholesterol Guideline: How to Handle the High-Risk Patients

Feat. K. Birtcher
16:50
Advances in Cardiovascular Disease Prevention

Paradigm Shifts: Understanding and Applying the Latest Lipid Guideli…

Feat. A. Freeman
17:47
Zachary Noel

Potential for Drug-Drug Interactions to Lead to Statin Intolerance

41:33
National Lipid Association

New Drugs in Development for Dyslipidemia

15:25
Mike Kelly

Management of Statin Intolerance

06:07
Cleveland Clinic Heart, Vascular and Thoracic Institute

Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients Wit…

Feat. S. Nissen
60:52
The North American Thrombosis Forum (NATF)

Current Treatments for LDL Lowering — and Why Patient Access Is So I…

Feat. J. Plutzky, H. Johnson, S. Martin